Is a 5mm obstructive stone in the distal left ureter with a density of 1033 Hounsfield Units (HU) and associated mild left hydroureteronephrosis a candidate for Extracorporeal Shock Wave Lithotripsy (ESWL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ESWL for 5mm Distal Ureteral Stone with High Density (1033 HU)

ESWL is a reasonable first-line treatment option for this 5mm distal ureteral stone, though ureteroscopy may offer superior stone-free rates with a single procedure. 1

Treatment Decision Framework

Stone Characteristics Favoring ESWL

  • Stone size <10mm makes ESWL an acceptable option according to the 2007 AUA guidelines, which specifically include distal ureteral stones in this size range as candidates for shock wave lithotripsy 1
  • The mild hydroureteronephrosis indicates the stone is causing obstruction but not severe enough to mandate urgent intervention 1

Critical Limitation: Stone Density

  • The 1033 HU density is a significant concern - stones with density >1000 HU (particularly calcium oxalate monohydrate) have substantially lower fragmentation rates with ESWL 2
  • High-density stones often require multiple ESWL sessions or ultimately fail, necessitating salvage ureteroscopy 3

Comparative Treatment Outcomes

ESWL Performance for Distal Stones

  • Stone-free rates for distal ureteral stones <10mm with ESWL range from 84-96% depending on the lithotripter used 4
  • Retreatment rates are significantly higher with ESWL (4-14% require additional sessions) compared to ureteroscopy 4, 5
  • ESWL has lower complication rates (RR 0.54) and shorter hospital stays compared to ureteroscopy 5

Ureteroscopy Performance

  • Ureteroscopy achieves 100% stone-free rates for distal stones in this size range with a single procedure 4
  • For stones <10mm, ureteroscopy is more cost-efficient and provides superior outcomes, though it requires general anesthesia and routine stent placement 3
  • The 2007 AUA guidelines show ureteroscopy has higher initial success but increased complication rates (particularly ureteral injury at 3% and stricture at 1%) 1

Recommendation Algorithm

ESWL is appropriate if:

  • Patient prefers less invasive approach with outpatient treatment under IV sedation 4
  • Patient accepts potential need for retreatment (up to 14% chance) 4
  • No contraindications to general anesthesia exist for potential salvage ureteroscopy 3

Ureteroscopy should be strongly considered instead if:

  • Stone density >1000 HU predicts ESWL failure - this is your case 2
  • Patient desires single-procedure definitive treatment 5
  • Symptoms are severe or infection is present 1

Critical Pitfalls to Avoid

  • Never perform blind basketing (stone extraction without endoscopic visualization) - this carries high risk of ureteral injury and is contraindicated 1
  • Do not delay treatment beyond 4-6 weeks if obstruction persists, as this risks irreversible renal damage 6
  • Screen for infection before any intervention - untreated bacteriuria with obstruction can lead to urosepsis, particularly with ESWL or endoscopic manipulation 1
  • Avoid routine stenting with ESWL as it lowers both fragmentation and stone-free rates 3

Practical Considerations

Given the 1033 HU density, ureteroscopy with laser lithotripsy is likely the superior first-line choice despite ESWL being technically indicated for stone size. The high density substantially increases the probability of ESWL failure, making ureteroscopy more cost-effective overall by avoiding multiple procedures 3. However, if patient factors strongly favor ESWL (inability to tolerate anesthesia, patient preference for less invasive approach), it remains a reasonable option with close follow-up planned for potential retreatment 1, 4.

Related Questions

Is Flomax (Tamsulosin) effective for women with ureteral stones measuring 4 millimeters in diameter?
What is the management for a 7mm stone in the proximal right ureter at the level of the L3 vertebral body with mild upstream hydroureteronephrosis and a density of 1375 Hounsfield Units (HU), indicated for Extracorporeal Shock Wave Lithotripsy (ESWL)?
What should a patient with a 5mm ureteral stone, unable to pass for 5 days, and ongoing pain do?
Can flavoxate be used to treat ureteric stones?
What is the significance of a 4 cm calculus at the left ureterovesical (ureterovesicular) junction, indicating a left mid-pole renal calculus that has migrated distally?
What is the diagnosis and recommended management for an elderly patient presenting with right upper abdominal pain, a distended gallbladder with mobile gallstones and biliary sludge on ultrasound, and no evidence of other hepatic or biliary abnormalities?
What is the treatment approach for an adult patient with a confirmed diagnosis of clear cell carcinoma, likely of the kidney or ovary?
What is the best course of treatment for a adult patient, possibly with a history of smoking or poor oral hygiene, presenting with dry socket after a tooth extraction?
Why is vancomycin given to patients post dialysis, particularly those with compromised immune systems and at high risk for infections related to the dialysis access site?
What are the red flag signs in patients presenting with loss of consciousness?
What is the recommended duration of albendazole (Anti-parasitic medication) treatment for a patient diagnosed with Neurocysticercosis (NCC)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.